Cargando…

Expanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in newborns from Xinxiang city in China

BACKGROUND: Tandem mass spectrometry is a powerful technology available in China over the last 15 years. The development of tandem mass spectrometry had made it possible to rapidly screen newborns for inborn errors of metabolism. The aim of this study was to determine the birth incidence of inborn e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shujun, Guo, Qinghe, Zhang, Zhongxin, He, Zhian, Yue, Aizhi, Song, Zhishan, Zhao, Qingwei, Wang, Xia, Sun, Ruili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246475/ https://www.ncbi.nlm.nih.gov/pubmed/31916308 http://dx.doi.org/10.1002/jcla.23159

Ejemplares similares

Application of Next-Generation Sequencing Following Tandem Mass Spectrometry to Expand Newborn Screening for Inborn Errors of Metabolism: A Multicenter Study
por: Yang, Yuqi, et al.
Publicado: (2019)

Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population
por: Wang, Ting, et al.
Publicado: (2019)

Maternal Inborn Errors of Metabolism Detected in Expanded Newborn Metabolic Screening
por: Tin, Oğuzhan, et al.
Publicado: (2023)

Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region
por: Martín‐Rivada, Álvaro, et al.
Publicado: (2022)

Expanded Newborn Screening for Inborn Errors of Metabolism and Genetic Characteristics in a Chinese Population
por: Guo, Kejian, et al.
Publicado: (2018)

Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry
por: Padilla, Carmencita D., et al.
Publicado: (2022)

Future Perspectives of Newborn Screening for Inborn Errors of Immunity
por: Blom, Maartje, et al.
Publicado: (2021)

Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population
por: Zhang, Ruixue, et al.
Publicado: (2021)

Moroccan Experience of Targeted Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry
por: Meiouet, Faïza, et al.
Publicado: (2023)

Tandem Mass Spectrometry Screening for Inborn Errors of Metabolism in Newborns and High-Risk Infants in Southern China: Disease Spectrum and Genetic Characteristics in a Chinese Population
por: Tan, Jianqiang, et al.
Publicado: (2021)

A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns
por: Onuki, Takanori, et al.
Publicado: (2023)

Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China
por: Yang, Chi-Ju, et al.
Publicado: (2018)

Expanded Newborn Screening Using Tandem Mass Spectrometry: Seven Years of Experience in Eastern Sicily
por: Messina, MariaAnna, et al.
Publicado: (2018)

Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience
por: Ruoppolo, Margherita, et al.
Publicado: (2022)

Non-derivatizing Tandem Mass Spectrometry Assay for Expanded Newborn Screening and Cutoffs for Preterm Neonates
por: Lee, Joon Hee, et al.
Publicado: (2023)

The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020)

Inborn error of metabolism precipitated by COVID-19: challenges in the absence of an expanded newborn screening as state health programmes
por: Olety, Priyanka, et al.
Publicado: (2022)

An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand
por: Thiboonboon, Kittiphong, et al.
Publicado: (2015)

Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan
por: Shigematsu, Yosuke, et al.
Publicado: (2021)

Expanded newborn screening for inherited metabolic disorders by tandem mass spectrometry in a northern Chinese population
por: Zhang, Hong, et al.
Publicado: (2022)

Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs
por: Gelb, Michael H., et al.
Publicado: (2017)

Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories
por: Gelb, Michael H., et al.
Publicado: (2022)

Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia
por: Khan, Adbul Rafiq, et al.
Publicado: (2022)

Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations
por: King, Jovanka R., et al.
Publicado: (2023)

Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate
por: Cohen, Arieh S., et al.
Publicado: (2019)

Postanalytical tools improve performance of newborn screening by tandem mass spectrometry
por: Hall, Patricia L., et al.
Publicado: (2014)

An Easily Overlooked Contamination of Syringes in Newborn Screening by Tandem Mass Spectrometry
por: Wang, Yanyun, et al.
Publicado: (2021)

Expanded Newborn Screening Program in Slovenia using Tandem Mass Spectrometry and Confirmatory Next Generation Sequencing Genetic Testing
por: Lampret, Barbka Repič, et al.
Publicado: (2020)

Newborn Sickle Cell Disease Screening Using Electrospray Tandem Mass Spectrometry
por: Daniel, Yvonne, et al.
Publicado: (2018)

Editorial: Newborn Screening for Inborn Errors of Metabolism: Is It Time for a Globalized Perspective Based on Genetic Screening?
por: Elmonem, Mohamed A., et al.
Publicado: (2021)

Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry
por: Yoon, Hye-Ran
Publicado: (2015)

Identification of a frit-related sample carryover in newborn screening by tandem mass spectrometry
por: Kim, Kyunghun, et al.
Publicado: (2023)

Quantitation of non-derivatized free amino acids for detecting inborn errors of metabolism by incorporating mixed-mode chromatography with tandem mass spectrometry
por: DeArmond, Patrick D., et al.
Publicado: (2022)

Diagnosing lysosomal storage diseases in a Brazilian non-newborn population by tandem mass spectrometry
por: Brand, Guilherme Dotto, et al.
Publicado: (2013)

Improved Reagents for Newborn Screening of Mucopolysaccharidosis Types I, II, and VI by Tandem Mass Spectrometry
por: Chennamaneni, Naveen Kumar, et al.
Publicado: (2014)

Erratum to: Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry
por: Yoon, Hye-Ran
Publicado: (2015)

Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry()
por: Elliott, Susan, et al.
Publicado: (2016)

Response to Gelb et al.: “Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs”
por: Millington, David S.
Publicado: (2017)

Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening
por: Cicalini, Ilaria, et al.
Publicado: (2021)

Establishment of Cutoff Values for Newborn Screening of Six Lysosomal Storage Disorders by Tandem Mass Spectrometry
por: Li, Ruotong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jm5kf86itupon841nu5rdi3d42